Roche launches CoaguChek Pro II system to determine coagulation status of patients at all points of care
CoaguChek Pro II combines two tests in a single device - the activated partial thromboplastin time (aPTT) test and the prothrombin time (PT) test with extended claims - for...Learn more

Roche launches low-volume lab-coagulation portfolio with the new cobas t 411 analyzer
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its new lab-coagulation solution, the cobas t 411 analyzer, is now available for countries accepting...Learn more